Cargando…
Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) in hormone metabolism pathways might cause metabolic disturbances and contribute to the development of polycystic ovary syndrome (PCOS) and ovarian cancer, but the published studies were inconsistent. The aim of the present study was to ev...
Autores principales: | Xiong, Ying, Bian, Ce, Lin, Xiaojuan, Wang, Xiaoli, Xu, Kehui, Zhao, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7369393/ https://www.ncbi.nlm.nih.gov/pubmed/32639550 http://dx.doi.org/10.1042/BSR20200995 |
Ejemplares similares
-
Prevalence of Methylenetetrahydrofolate Reductase
C677T Polymorphism in women with Polycystic
Ovary Syndrome in southeast of Iran
por: Naghavi, A, et al.
Publicado: (2015) -
Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies
por: Wang, Lihong, et al.
Publicado: (2017) -
Significant association between methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: A meta-analysis update
por: Li, Yin, et al.
Publicado: (2020) -
Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility: an updated meta-analysis
por: Wang, Yuwei, et al.
Publicado: (2023) -
Methylenetetrahydrofolate Reductase Polymorphisms and Pregnancy Outcome
por: Turgal, Mert, et al.
Publicado: (2018)